Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Feasibility of methotrexate discontinuation following tocilizumab and methotrexate combination therapy in patients with long-standing and advanced rheumatoid arthritis: a 3-year observational cohort study.
Miyata M, Hirabayashi Y, Munakata Y, Urata Y, Saito K, Okuno H, Yoshida M, Kodera T, Watanabe R, Miyamoto S, Ishii T, Nakazawa S, Takemori H, Ando T, Kanno T, Komagamine M, Kato I, Takahashi Y, Komatsuda A, Endo K, Murai C, Takakubo Y, Miura T, Sato Y, Ichikawa K, Konta T, Chiba N, Muryoi T, Kobayashi H, Fujii H, Sekiguchi Y, Hatakeyama A, Ogura K, Sakuraba H, Asano T, Kanazawa H, Suzuki E, Takasaki S, Asakura K, Suzuki Y, Takagi M, Nakayama T, Watanabe H, Miura K, Mori Y; Michinoku Tocilizumab Study Group. Miyata M, et al. Among authors: muryoi t. Fukushima J Med Sci. 2023 Apr 5;69(1):11-20. doi: 10.5387/fms.2022-06. Epub 2023 Mar 30. Fukushima J Med Sci. 2023. PMID: 36990790 Free PMC article. Retracted.
Clinical and structural remission rates increased annually and radiographic progression was continuously inhibited during a 3-year administration of tocilizumab in patients with rheumatoid arthritis: A multi-center, prospective cohort study by the Michinoku Tocilizumab Study Group.
Hirabayashi Y, Munakata Y, Miyata M, Urata Y, Saito K, Okuno H, Yoshida M, Kodera T, Watanabe R, Miyamoto S, Ishii T, Nakazawa S, Takemori H, Ando T, Kanno T, Komagamine M, Kato I, Takahashi Y, Komatsuda A, Endo K, Murai C, Takakubo Y, Miura T, Sato Y, Ichikawa K, Konta T, Chiba N, Muryoi T, Kobayashi H, Fujii H, Sekiguchi Y, Hatakeyama A, Ogura K, Sakuraba H, Asano T, Kanazawa H, Suzuki E, Takasaki S, Asakura K, Sugisaki K, Suzuki Y, Takagi M, Nakayama T, Watanabe H, Miura K, Mori Y; Michinoku Tocilizumab Study Group. Hirabayashi Y, et al. Among authors: muryoi t. Mod Rheumatol. 2016 Nov;26(6):828-835. doi: 10.3109/14397595.2016.1160991. Epub 2016 Apr 21. Mod Rheumatol. 2016. PMID: 26934116
Rheumatoid arthritis after human parvovirus B19 infection.
Murai C, Munakata Y, Takahashi Y, Ishii T, Shibata S, Muryoi T, Funato T, Nakamura M, Sugamura K, Sasaki T. Murai C, et al. Among authors: muryoi t. Ann Rheum Dis. 1999 Feb;58(2):130-2. doi: 10.1136/ard.58.2.130. Ann Rheum Dis. 1999. PMID: 10343531 Free PMC article. No abstract available.
Somatic mutation in autoantibody-associated VH genes of circulating IgM+IgD+ B cells.
Munakata Y, Saito S, Hoshino A, Muryoi T, Hirabayashi Y, Shibata S, Miura T, Ishii T, Funato T, Sasaki T. Munakata Y, et al. Among authors: muryoi t. Eur J Immunol. 1998 May;28(5):1435-44. doi: 10.1002/(SICI)1521-4141(199805)28:05<1435::AID-IMMU1435>3.0.CO;2-R. Eur J Immunol. 1998. PMID: 9603448 Free article.
Persistent infection of human parvovirus B19 in a normal subject.
Sasaki T, Murai C, Muryoi T, Takahashi Y, Munakata Y, Sugamura K, Abe K. Sasaki T, et al. Among authors: muryoi t. Lancet. 1995 Sep 23;346(8978):851. doi: 10.1016/s0140-6736(95)91673-3. Lancet. 1995. PMID: 7674787 No abstract available.
Tight-skin mouse an experimental model for scleroderma.
Kasturi KN, Shibata S, Muryoi T, Bona CA. Kasturi KN, et al. Among authors: muryoi t. Int Rev Immunol. 1994;11(3):253-71. doi: 10.3109/08830189409061731. Int Rev Immunol. 1994. PMID: 7523551 Review. No abstract available.
36 results